lglutamine and glutathione glutamine analogues that inhibit GGT. Shown are the L-Glutamine , 500 mg ,

TABLE 2 Sulforaphane provides neuroprotection in NDD models through activation of the antioxidant NRF2/ARE pathway This table illustrates the neuroprotective properties of SFN in various pre-clinical models of AD, PD and MS

10.1097/LGT.0b013e31829156ec 171

The remarkable aspects of this case are its rather impressive clinical presentation and its occurrence in a male patient, which have rarely been described

Interestingly, the authors also identified carbonic anhydrase as one of the targets for Triphala metabolites, which aligns with the findings of our study 91

Calabrese V, Cornelius C, Mancuso C, Pennisi G, Calafato S, Bellia F et al

If LDN is prescribed you are likely to have a slow dosage increase over initial few weeks (for example, beginning with a 1.5 mg daily for the first week and increasing to 4.5 over 3 weeks if well tolerated 13 )